Home
>
US Stocks
>
G1 Therapeutics Inc
G1 Therapeutics Inc
GTHX

G1 Therapeutics Inc (GTHX)

$13.266.22%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
13.42
Today Low/High
13.17 / 13.65
52 Week Low/High
$10.81 / $37.07
Market Cap
$600.5M

Company Details

G1 Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on the discovery, development and delivery of next generation therapies that improve the lives of those affected by cancer, including the Company's first commercial product, COSELA™ (trilaciclib). G1 has a deep clinical pipeline evaluating targeted cancer therapies in a variety of solid tumors, including colorectal, breast, lung, and bladder cancers. G1 Therapeutics is based in Research Triangle Park, N.C.
Organisation
G1 Therapeutics Inc
Headquaters
Research Triangle Park, North Carolina, US
Employees
122
Industry
Health Technology
CEO
Mark Velleca

Discover more

Frequently Asked Questions

What is G1 Therapeutics Inc (GTHX) share price today?

Can Indians buy G1 Therapeutics Inc (GTHX) shares?

How can I buy G1 Therapeutics Inc (GTHX) shares from India?

Can Fractional shares of G1 Therapeutics Inc (GTHX) be purchased?

What are the documents required to start investing in G1 Therapeutics Inc (GTHX) stocks?

We are a SEBI registered investement advisor